Ameliorative potential of Vernonia cinerea on chronic constriction injury of sciatic nerve induced neuropathic pain in rats

Abstract

The aim of the present study is to investigate the ameliorative potential of ethanolic extract of whole plant of Vernonia cinerea in the chronic constriction injury (CCI) of sciatic nerve induced neuropathic pain in rats. Behavioral parameters such as a hot plate, acetone drop, paw pressure, Von Frey hair and tail immersion tests were performed to assess the degree of thermal, chemical and mechanical hyperalgesia and allodynia. Biochemical changes in sciatic nerve tissue were ruled out by estimating thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH) and total calcium levels. Ethanolic extract of Vernonia cinerea and pregabalin were administered for 14 consecutive days starting from the day of surgery. CCI of sciatic nerve has been shown to induce significant changes in behavioral, biochemical and histopathological assessments when compared to the sham control group. Vernonia cinerea attenuated in a dose dependent manner the above pathological changes induced by CCI of the sciatic nerve, which is similar to attenuation of the pregabalin pretreated group. The ameliorating effect of ethanolic extract of Vernonia cinerea against CCI of sciatic nerve induced neuropathic pain may be due to the presence of flavonoids and this effect is attributed to anti-oxidative, neuroprotective and calcium channel modulator actions of these compounds.

Ameliorative effect of gallic acid in paclitaxel-induced neuropathic pain in mice

“…Our recent findings revealed that alteration of a neuronal microvascular system is primary cardinal signs for the damage and degeneration of the nervous system [[68], [69], [70]]. Furthermore, some of our studies and other laboratory reports recommended that plant extracts and nutritional products of Acorus calamus [51,70], Butea monosperma [71], Swietenia mahagoni [72], Ocimum sanctum [73] and Vernonia cinerea [74] mitigate neuropathic pain symptoms. Phytoconstituents like puerarin [75], bulleyaconitine A [76], thymoquinone, epigallocatechin gallate, lycopene and resveratrol [17] produced an anti-neuralgic effect.…”

N-type calcium channel blockers: a new approach towards the treatment of chronic neuropathic pain

“…There are also several non-peptide small molecules under preclinical and clinical trials but till no successful outcome has been noticed. But of course, because of the small size and non-peptide nature they can lead to the development of molecule that can follow an alternate route with fewer side effects and more specific to the receptor [215][216][217][218][219][220][221]. In recent years, lots of review and research have been published on recent advancements of nanotechnology and their application on neurological disease as well as NP [222][223][224][225][226][227][228][229][230][231][232][233].…”

Murraya paniculata (L.) Jack: A Potential Plant for Treatment of Toothache

“…The antiinflammatory effect of hydroalcoholic extract of Lampaya medicinalis has been attributed to presence of flavonoids in the extract [18]. The ameliorative potential of ethanolic extract of whole plant of Vernonia cinerea in the Chronic Constriction Injury (CCI) of sciatic nerve induced neuropathic pain in rats has also been attributed to flavonoids [19]. The antinociceptive and anti-inflammatory of flower extract of Alangium salvifolium has been attributed to presence of alkaloids and flavonoids in the extract [20].…”